Investment Options: Sonde Resources Corp (USA)(NYSEMKT:SOQ), Echo Therapeutics Inc(NASDAQ:ECTE) And Medbox Inc(OTCMKTS:MDBX)
New York, NY – GDP INSIDER – 11/11/2014.
This article discusses three companies: Sonde Resources Corp (USA)(NYSEMKT:SOQ), Echo Therapeutics Inc(NASDAQ:ECTE) And Medbox Inc(OTCMKTS:MDBX)
Sonde Resources Corp (USA)(NYSEMKT:SOQ) saw its value decline by an extremely detrimental 28.77% as the stock lost $0.0210 during trading yesterday. Finishing the day at a closing price of $0.0520 after opening the day at a mark of $0.07, the stock is now situated just $0.002 above its 52 week low of $0.05 and $0.928 below its 52 week high of $0.98. The $3.51 million market cap company, has lost a massive 77.39% in value over a period of three months.
Echo Therapeutics Inc(NASDAQ:ECTE) suffered a 4.97% loss in value during yesterday’s trading as the stock fell $0.033 to move to a new closing price of $0.637, a figure which is just $0.357 above the company’s 52 week low of $0.39 and $4.273 away from its 52-week low of $4.91. The $9.01 million market cap company traded 28,789 shares yesterday with an average 30-days volume of 55,822 shares. The stock has been plummeted 79.71% in value YTD.
Medbox Inc(OTCMKTS:MDBX) lost ninety one cents to move to a new closing price of $9.99. The stock has traded within a range of $7.90 to $93.50 over the past 52 weeks. The $299.8 million company, which has a 50 days simple moving average of $10.26, has seen its value decline by 49.82% over the past 6 months. The highly overpriced stock has suffered a whooping 72% drop in its revenue compared to the same period last year.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.